Weight-loss jabs linked to reduced risk of 42 conditions including dementia

Psychotic disorders also among conditions found less likely when people with diabetes took medications found in jabs

People with diabetes taking medications found in weight-loss jabs have a reduced risk of 42 conditions, research has found, paving the way for such drugs being used to treat a host of health problems.

The most comprehensive study of its kind showed that psychotic disorders, infections and dementia were among conditions found to be less likely to occur when using GLP-1RAs, which are found in the medications Saxenda, Wegovy and Mounjaro.